Chinese English Japanese Korean

Shanghai Aladdin Biochemical Technology Co.,Ltd.

Firmenname:Shanghai Aladdin Biochemical Technology Co.,Ltd.
Telefon:400-6206333
E-Mail:market@aladdin-e.com
Nationalität:China
URL: www.aladdin-e.com/
Produkte insgesamt:48467
460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485

Produktkatalog

Urea-13C58069-82-2CH4N2O
Telazorlimab (anti-TNFRSF4)2126777-87-3
Dysprosium(III) trifluoromethanesulfonate139177-62-1C3DyF9O9S3
Bis(hexamethylene)triamine7-Azatridecan-1,13-diamin143-23-7C12H29N3
Dehydroepiandrosterone sulfate651-48-9C19H28O5S
Xentuzumab (anti-IGF1)1417158-65-6
Bimagrumab (anti-ACVR2B)1356922-05-8
XP-59890402-73-0C15H14N4O2
Meropenem-d61133424-00-6C17H25N3O5S
Imazapic104098-48-8C14H17N3O3
IDO-IN-132291164-02-6C26H17F3N4O
(W) PhenyldichlorosilaneDichlorphenylsilan1631-84-1C6H6Cl2Si
Ethyl 2-oxo-4-phenylbutyrateEthyl-2-oxo-4-phenylbutyrat64920-29-2C12H14O3
Ranibizumab (anti-VEGFA)347396-82-1C11H12N2O2
Nadecnemab (anti-GFRA3)2377679-19-9
Benzyldiphenylphosphine7650-91-1C19H17P
Quetmolimab (anti-CX3CL1)2084037-83-0
Codrituzumab (anti-GPC3)1365267-33-9
Bexmarilimab (anti-STAB1)2259301-27-2
Narsoplimab (anti-MASP2)2108782-45-0
8-Azahypoxanthine4,5-Dihydro-1H-triazolo[4,5-d]pyrimidin-4-ol2683-90-1C4H3N5O
Sirtratumab (anti-SLITRK6)1824663-82-2
Rosmantuzumab (anti-RSPO3)1684393-04-1
Bivatuzumab (anti-CD44v6)214559-60-1
Apelin 17 TFA217082-57-0C96H156N34O20S
Tamrintamab (anti-DPEP3)2148325-59-9
Cinpanemab (anti-Alpha-synuclein)2094516-02-4
Mogamulizumab (anti-CCR4)1159266-37-1
Alizarin Yellow R sodium saltNatrium-5-[(4-nitrophenyl)azo]salicylat1718-34-9C13H8N3NaO5
2-(azetidin-1-yl)ethan-1-amine795299-77-3C5H12N2
Tesnatilimab (anti-NKG2D)2242758-08-1
Lacnotuzumab (anti-M-CSF)1831128-32-5
Tesidolumab (anti-Complement C5)1531594-08-7
Sonepcizumab (anti-Sphingosine-1-phosphate)1031360-18-5
Urelumab (anti-TNFRSF9)934823-49-1
Elotuzumab (anti-SLAMF7)915296-00-3
Galiximab (anti-CD80)357613-77-5
Idactamab (anti-SLC1A5)2245205-37-0
Apamistamab (anti-PTPRC)2097132-02-8
Ravulizumab (anti-Complement C5)1803171-55-2
Itolizumab (anti-CD6)1116433-11-4
Lumiliximab (anti-FceR2)357613-86-6
Vopratelimab (anti-ICOS)2039148-04-2
KWAR23 (anti-SIRPg)2243227-60-1
Narnatumab (anti-RON)1188275-92-4
Tisotumab (anti-F3)1418628-81-5
Zagotenemab (anti-Tau)2019133-28-7
Vandortuzumab (anti-STEAP1)1557989-52-2
Ladiratuzumab (anti-SLC39A6)1629760-28-6
Concizumab (anti-TFPI)1312299-39-0
Serplulimab (anti-PDCD1)2231029-82-4
Vunakizumab (anti-IL-17a)1792181-33-9
Indusatumab (anti-GUCY2C)1497400-26-6
Ulocuplumab (anti-CXCR4)1375830-34-4
Vantictumab (anti-FZD)1345009-45-1
Fulranumab (anti-NGF)902141-80-4
Ianalumab (anti-TNFRSF13C)1929549-92-7
Lexatumumab (anti-TNFRSF10B)845816-02-6
Gevokizumab (anti-IL-1b)1129435-60-4
Pascolizumab (anti-IL-4)331243-22-2
Gemtuzumab (anti-CD33)220578-59-6
Seribantumab (anti-ERBB3)1334296-12-6
Tarextumab (anti-NOTCH3)1359940-55-8
Zansecimab (anti-ANGPT2)2415205-37-5
Vorsetuzumab (anti-CD70)1165740-62-4
Lemzoparlimab (anti-CD47)2377483-71-9
Flanvotumab (anti-TYRP1)1188277-05-5
Guselkumab (anti-IL-23)1350289-85-8
Ixekizumab (anti-CTLA-8)1143503-69-8
Oxelumab (anti-TNFSF4)1186098-83-8
Sirukumab (anti-IL-6)1194585-53-9
Ragifilimab (anti-TNFRSF18)2207590-51-8
Depatuxizumab mafodotin (anti-EGFR)1585973-65-4
Belimumab (anti-TNFSF13B)356547-88-1
Dostarlimab (anti-PD-1)2022215-59-2
Daclizumab (anti-IL2RA)152923-56-3
Tinurilimab (anti-CEACAM6)2226224-30-0
Otilimab (anti-GM-CSF)1638332-55-4
Ocrelizumab (anti-CD20)637334-45-3C19H16N2O5
Rilotumumab (anti-HGF)872514-65-3
Emibetuzumab (anti-MET)1365287-97-3
Enfortumab (anti-NECTIN4)1448664-46-7
Prezalumab (anti-B7-H2)1523164-68-2
Enoblituzumab (anti-CD276)1353485-38-7
Avdoralimab (anti-C5AR1)2226393-85-5
Labetuzumab govitecan (anti-CEACAM5)1469876-18-3
Girentuximab (anti-CA9)916138-87-9
Datopotamab (anti-TROP2)2267989-53-5
Imaprelimab (anti-CD146)2014343-04-3
Abelacimab(anti-Factor XI)2098724-83-3
Dinutuximab (anti-GD2)1363687-32-4
Efalizumab (anti-ITGAL)214745-43-4
Carotuximab (anti-CD105)1268714-50-6
Ontamalimab (anti-MADCAM1)2098790-40-8
Brazikumab (anti-IL-23)1610353-18-8
Enokizumab (anti-IL-9)909875-08-7
Eldelumab (anti-CXCL10)946414-98-8
Daxdilimab (anti-ILT7)2245966-28-1
Bermekimab (anti-IL-1a)1401965-15-8
Ponsegromab (anti-GDF15)2368950-15-4
460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485
Copyright 2019 © ChemicalBook. All rights reserved